The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause
Academic Article
Publication Date:
2012
Short description:
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause / Chirgwin, J., Sun, Z., Smith, I., Price, K.n., Thürlimann, B., Ejlertsen, B., Bonnefoi, H., Regan, M.m., Goldhirsch, A., Coates, A.s., BIG 1-98 Collaborative and International Breast Cancer Study Group, ., Mastropasqua, M., ., ...).. - In: BREAST CANCER RESEARCH AND TREATMENT. - ISSN 0167-6806. - 131:(2012), pp. 295-306.
Iris type:
1.1 Articolo in rivista
List of contributors:
Chirgwin, J; Sun, Z; Smith, I; Price, Kn; Thürlimann, B; Ejlertsen, B; Bonnefoi, H; Regan, Mm; Goldhirsch, A; Coates, As; BIG 1-98 Collaborative and International Breast Cancer Study Group, (. . .; Mastropasqua, M; ., . . . )
Published in: